Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97% Market Closed
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Panacea Biotec Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Other Current Assets
â‚ą674.3m
CAGR 3-Years
-16%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Other Current Assets
â‚ą123.5m
CAGR 3-Years
-2%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Other Current Assets
â‚ą8.4m
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Other Current Assets
â‚ą9.8m
CAGR 3-Years
30%
CAGR 5-Years
-12%
CAGR 10-Years
20%
Hester Biosciences Ltd
NSE:HESTERBIO
Other Current Assets
â‚ą197.9m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Other Current Assets
â‚ą3B
CAGR 3-Years
-14%
CAGR 5-Years
4%
CAGR 10-Years
12%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Other Current Assets?
Other Current Assets
674.3m INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Other Current Assets amounts to 674.3m INR.

What is Panacea Biotec Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-27%

Over the last year, the Other Current Assets growth was -8%. The average annual Other Current Assets growth rates for Panacea Biotec Ltd have been -16% over the past three years , -27% over the past five years .

Back to Top